New serological markers in inflammatory bowel disease are associated with complicated disease behaviour von Ferrante, Marc, Henckaerts, Liesbet, Joossens, Marie, Pierik, Marie, Joossens, Sofie, Dotan, Nir, Norman, Gary L, Altstock, Rom T, Van Steen, Kristel, Rutgeerts, Paul, Van Assche, Gert, Vermeire, Séverine

Volltext

The value of serologic markers in indeterminate colitis: A prospective follow-up study von Joossens, Sofie, Reinisch, Walter, Vermeire, Séverine, Sendid, Boualem, Poulain, Daniel, Peeters, Marc, Geboes, Karel, Bossuyt, Xavier, Vandewalle, Peggy, Oberhuber, Georg, Vogelsang, Harald, Rutgeerts, Paul, Colombel, Jean-Frédéric

Volltext

Toll‐like receptor‐1, ‐2, and ‐6 polymorphisms influence disease extension in inflammatory bowel diseases von Pierik, Marie, Joossens, Sofie, Van Steen, Kristel, Van Schuerbeek, Nele, Vlietinck, Robert, Rutgeerts, Paul, Vermeire, Severine

Volltext

Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort study von Vermeire, Severine, Noman, Maja, Van Assche, Gert, Baert, Filip, Van Steen, Kristel, Esters, Nele, Joossens, Sofie, Bossuyt, Xavier, Rutgeerts, Paul

Volltext

Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease von HLAVATY, T., PIERIK, M., HENCKAERTS, L., FERRANTE, M., JOOSSENS, S., SCHUERBEEK, N., NOMAN, M., RUTGEERTS, P., VERMEIRE, S.

Volltext

Tumour necrosis factor‐α receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab von Pierik, M., Vermeire, S., Steen, K. V., Joossens, S., Claessens, G., Vlietinck, R., Rutgeerts, P.

Volltext

Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis von Vermeire, S, Rutgeerts, P, Van Steen, K, Joossens, S, Claessens, G, Pierik, M, Peeters, M, Vlietinck, R

Volltext

Anti-outer membrane of porin C and anti-I2 antibodies in indeterminate colitis von Joossens, S, Colombel, J-F, Landers, C, Poulain, D, Geboes, K, Bossuyt, X, Targan, S, Rutgeerts, P, Reinisch, W

Volltext

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn’s disease von Esters, N, Vermeire, S, Joossens, S, Noman, M, Louis, E, Belaiche, J, De Vos, M, Van Gossum, A, Pescatore, P, Fiasse, R, Pelckmans, P, Reynaert, H, Poulain, D, Bossuyt, X, Rutgeerts, P

Volltext

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease von Esters, N, Vermeire, S, Joossens, S, Noman, M, Louis, E, Belaiche, J, De Vos, M, Van Gossum, A, Pescatore, P, Fiasse, R, Pelckmans, P, Reynaert, H, Poulain, D, Bossuyt, X, Rutgeerts, P

Volltext

Pancreatic autoantibodies in inflammatory bowel disease von Joossens, Sofie, Vermeire, Severine, Van Steen, Kristel, Godefridis, Godelieve, Claessens, Greet, Pierik, Marie, Vlietinck, Robert, Aerts, Raymond, Rutgeerts, Paul, Bossuyt, Xavier

Volltext

Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn’s disease von Joossens, S, Pierik, M, Rector, A, Vermeire, S, Ranst, M V, Rutgeerts, P, Bossuyt, X

Volltext

Diagnostic value of anti- Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease von Peeters, Marc, Joossens, Sofie, Vermeire, Severine, Vlietinck, Robert, Bossuyt, Xavier, Rutgeerts, Paul

Volltext

Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn’s Disease von Amcoff, Karin, Joossens, Marie, Pierik, Marie J., Jonkers, Daisy, Bohr, Johan, Joossens, Sofie, Romberg-Camps, Mariëlle, Nyhlin, Nils, Wickbom, Anna, Rutgeerts, Paul J., Tysk, Curt, Bodin, Lennart, Colombel, Jean-Frederic, Vermeire, Severine, Halfvarson, Jonas

Volltext

Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial von Philipsen, Alexandra, Jans, Thomas, Graf, Erika, Matthies, Swantje, Borel, Patricia, Colla, Michael, Gentschow, Laura, Langner, Daina, Jacob, Christian, Groß-Lesch, Silke, Sobanski, Esther, Alm, Barbara, Schumacher-Stien, Martina, Roesler, Michael, Retz, Wolfgang, Retz-Junginger, Petra, Kis, Bernhard, Abdel-Hamid, Mona, Heinrich, Viola, Huss, Michael, Kornmann, Catherine, Bürger, Arne, Perlov, Evgeniy, Ihorst, Gabriele, Schlander, Michael, Berger, Mathias, Tebartz van Elst, Ludger

Volltext

The value of serologic markers in indeterminate colitis: A prospective follow-up study - Reply von Joossens, S., Van Steen, Kristel, Vermeire, S. V., Reinisch, W., Colombel, J. F., Rutgeerts, P.

Volltext

Comparative study of ASCA (Anti–Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease von Vermeire, Severine, Joossens, Sofie, Peeters, Marc, Monsuur, Fred, Marien, Godelieve, Bossuyt, Xavier, Groenen, Peter, Vlietinck, Robert, Rutgeerts, Paul

Volltext

Environmental factors in familial Crohn's disease in Belgium von Van Kruiningen, Herbert J, Joossens, Marie, Vermeire, Severine, Joossens, Sofie, Debeugny, Stéphane, Gower‐Rousseau, Corinne, Cortot, Antoine, Colombel, Jean‐Frédéric, Rutgeerts, Paul, Vlietinck, Robert

Volltext

CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed inte... von Gijsbers, Klara, Van Assche, Gert, Joossens, Sofie, Struyf, Sofie, Proost, Paul, Rutgeerts, Paul, Geboes, Karel, Van Damme, Jo

Volltext

Anti‐Saccharomyces Cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families von Vermeire, Severine, Peeters, Marc, Vlietinck, Robert, Joossens, Sofie, Hond, Elly Den, Bulteel, Veerle, Bossuyt, Xavier, Geypens, Benny, Rutgeerts, Paul

Volltext